IXC invex therapeutics ltd

Potential Invex Valuation, page-3

  1. 336 Posts.
    lightbulb Created with Sketch. 147
    There's lots of pitfalls with this valuation but it's specifically assuming blue sky where all the variables line up with Invex:
    - SP appreciates so options are exercised
    - Phase 3 is successful - based on Phase 2, I'd put it higher if it's Headache Days since it showed a >7 days improvement in Exenatide which wasn't even reformulated into Presendin.
    - And the biggest risk is whether Invex can convince the FDA to go 1 trial - and given they haven't seen the Phase 2 data yet, and with a leading KOI in Professor Sinclair, there is definitely upside if they get it right.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.1¢
Change
0.000(0.00%)
Mkt cap ! $6.839M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 33333 9.0¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 9000 1
View Market Depth
Last trade - 16.21pm 07/07/2025 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.